Outcome of hospital outpatient treatment of functional gastrointestinal disorders

被引:19
作者
Basnayake, Chamara [1 ,2 ]
Kamm, Michael A. [1 ,2 ]
Salzberg, Michael [2 ]
Stanley, Annalise [1 ]
Khera, Angela [1 ,2 ]
Burrell, Kathryn [1 ]
Wilson-O'Brien, Amy [1 ,2 ]
Hebbard, Geoffrey [2 ,3 ]
Thompson, Alexander J. [1 ,2 ]
机构
[1] St Vincents Hosp, Dept Gastroenterol, Melbourne, Vic 3065, Australia
[2] Univ Melbourne, Fac Med Dent & Hlth Sci, Melbourne, Vic, Australia
[3] Royal Melbourne Hosp, Dept Gastroenterol, Melbourne, Vic, Australia
关键词
irritable bowel syndrome; functional gastrointestinal disorder; hospital outpatient clinic; IRRITABLE-BOWEL-SYNDROME; CONTROLLED-TRIAL; BIOFEEDBACK; HYPNOTHERAPY; EPIDEMIOLOGY; CONSTIPATION; FEATURES;
D O I
10.1111/imj.14067
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Functional gastrointestinal disorders (FGID) are the commonest conditions observed in gastrointestinal (GI) practice, yet the outcomes of their outpatient care are not known. Aim: To evaluate the outcome for patients with FGID attending a specialist GI clinic. Methods: Consecutive, newly referred patients with a FGID attending a specialist GI clinic in a tertiary hospital, over a 1-year period were reviewed and then completed a phone survey to assess current symptoms. Results: Of 102 patients, 57% had irritable bowel syndrome, 28% functional dyspepsia and 15% other functional disorders. At interview, a median of 402 days after the last consultation 38% expressed symptom improvement, but 64% remained concerned about their condition despite 62% having been reassured. After treatment, 50% of employed patients took time off work because of gut symptoms. Functional dyspepsia patients were less likely to be symptomatically improved than other FGID (21% vs 45%, P = 0.02). Patients given a diet low in fermentable oligosaccharides, disaccharides, monosaccharides and polyols were more likely than others to achieve symptom improvement (53% vs 31%, P = 0.03); PPI-treated patients were less likely to experience improvement (22% vs 44%, P = 0.05); other treatments did not predict outcome. Number of visits, seniority of clinician, duration of care and comorbidities did not predict outcome. Conclusion: One year after attending a specialist GI clinic a minority of patients with FGID were symptomatically improved. Failure to benefit by many patients may relate to the nature of patients and conditions being treated or the limited nature and range of treatments offered. Different models of care, including more diverse multidisciplinary models, should be explored.
引用
收藏
页码:225 / 231
页数:7
相关论文
共 29 条
[1]  
Australian Institute of Health and Welfare, 2013, AUSTR HOSP STAT
[2]   American Gastroenterological Association Medical Position Statement on Constipation [J].
Bharucha, Adil E. ;
Dorn, Spencer D. ;
Lembo, Anthony ;
Pressman, Amanda .
GASTROENTEROLOGY, 2013, 144 (01) :211-217
[3]   Epidemiology of the functional gastrointestinal disorders diagnosed according to Rome II criteria: an Australian population-based study [J].
Boyce, PM ;
Talley, NJ ;
Burke, C ;
Koloski, NA .
INTERNAL MEDICINE JOURNAL, 2006, 36 (01) :28-36
[4]   Change in Quality of Life for Patients with Irritable Bowel Syndrome following Referral to a Gastroenterologist: A Cohort Study [J].
Canavan, Caroline ;
West, Joe ;
Card, Timothy .
PLOS ONE, 2015, 10 (10)
[5]   The epidemiology of irritable bowel syndrome [J].
Canavan, Caroline ;
West, Joe ;
Card, Timothy .
CLINICAL EPIDEMIOLOGY, 2014, 6 :71-80
[6]   American Gastroenterological Association Institute Technical Review on the Pharmacological Management of Irritable Bowel Syndrome [J].
Chang, Lin ;
Lembo, Anthony ;
Sultan, Shahnaz .
GASTROENTEROLOGY, 2014, 147 (05) :1149-+
[7]   Biofeedback is superior to laxatives for normal transit constipation due to pelvic floor dyssynergia [J].
Chiarioni, G ;
Whitehead, WE ;
Pezza, V ;
Morelli, A ;
Bassotti, G .
GASTROENTEROLOGY, 2006, 130 (03) :657-664
[8]   Biofeedback benefits only patients with outlet dysfunction, not patients with isolated slow transit constipation [J].
Chiarioni, G ;
Salandini, L ;
Whitehead, WE .
GASTROENTEROLOGY, 2005, 129 (01) :86-97
[9]   Biofeedback provides long term benefit for patients with intractable, slow and normal transit constipation [J].
Chiotakakou-Faliakou, E ;
Kamm, MA ;
Roy, AJ ;
Storrie, JB ;
Turner, IC .
GUT, 1998, 42 (04) :517-521
[10]   The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome [J].
Creed, F ;
Fernandes, L ;
Guthrie, E ;
Palmer, S ;
Ratcliffe, J ;
Read, N ;
Rigby, C ;
Thompson, D ;
Tomenson, B .
GASTROENTEROLOGY, 2003, 124 (02) :303-317